Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
Go back to Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway| (NASDAQ: LEXX) | Delayed: 3.32 +0.12 (3.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.20 | 52 Week High | $ | |||
| Open | $3.31 | 52 Week Low | $ | |||
| Day High | $3.90 | P/E | N/A | |||
| Day Low | $3.12 | EPS | $ | |||
| Volume | 200,606 | |||||



